Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.

Lőrincz H, Harangi M, Oláh AV, Szabó GP, Fülöp P, Somodi S, Paragh G, Seres I.

Pediatr Res. 2015 May;77(5):703-9. doi: 10.1038/pr.2015.33. Epub 2015 Feb 10.

PMID:
25668223
2.

Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.

Timár O, Szekanecz Z, Kerekes G, Végh J, Oláh AV, Nagy G, Csiki Z, Dankó K, Szamosi S, Németh Á, Soltész P, Szücs G.

Arthritis Res Ther. 2013;15(5):R105.

3.

Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions.

Gaál K, Lőrincz H, Seres I, Harangi M, Oláh AV, Paragh G.

Clin Biochem. 2013 Jun;46(9):825-7. doi: 10.1016/j.clinbiochem.2013.01.007. Epub 2013 Jan 24.

PMID:
23353781
4.

Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome.

Oláh AV, Szabó GP, Varga J, Balogh L, Csábi G, Csákváry V, Erwa W, Balogh I.

Eur J Pediatr. 2013 May;172(5):623-30. doi: 10.1007/s00431-012-1925-z. Epub 2013 Jan 15.

PMID:
23319240
5.

Mutational spectrum of smith-lemli-opitz syndrome patients in hungary.

Balogh I, Koczok K, Szabó GP, Török O, Hadzsiev K, Csábi G, Balogh L, Dzsudzsák E, Ajzner E, Szabó L, Csákváry V, Oláh AV.

Mol Syndromol. 2012 Nov;3(5):215-22. doi: 10.1159/000343923. Epub 2012 Nov 9.

6.

Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy.

Oláh AV, Asztalos L, Ivády G, Varga E, Kovács AM, Kappelmayer J, Varga J.

Clin Chem Lab Med. 2011 Nov;49(11):1849-53. doi: 10.1515/CCLM.2011.678. Epub 2011 Aug 18.

PMID:
21848499
7.

Hepatobiliary response in postoperative lipid therapy in gastrointestinal surgery.

Hallay J, Olah AV, Fulesdi B, Kocsor M, Vegh T, Kovacs G, Takacs I, Sapy P, Nagy D, Telessy IG.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1069-73.

PMID:
21410033
8.

A patient with Smith-Lemli-Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement.

Szabó GP, Oláh AV, Kozak L, Balogh E, Nagy A, Blahakova I, Oláh E.

Eur J Pediatr. 2010 Jan;169(1):121-3. doi: 10.1007/s00431-009-0987-z. Epub 2009 Apr 14.

PMID:
19365639
9.

Identification of sulfhemoglobinemia after surgical polypectomy.

Harangi M, Mátyus J, Nagy E, Nagy E, Paragh G, Balla J, Oláh AV.

Clin Toxicol (Phila). 2007;45(2):189-92.

PMID:
17364641
10.

Late effects on renal glomerular and tubular function in childhood cancer survivors.

Bárdi E, Oláh AV, Bartyik K, Endreffy E, Jenei C, Kappelmayer J, Kiss C.

Pediatr Blood Cancer. 2004 Nov;43(6):668-73.

PMID:
15390293
11.

Cystatin C is a suitable marker of glomerular function in children with cancer.

Bárdi E, Bobok I, Oláh AV, Oláh E, Kappelmayer J, Kiss C.

Pediatr Nephrol. 2004 Oct;19(10):1145-7. Epub 2004 Jul 16.

PMID:
15258844
12.

Age dependence of serum beta-N-acetylhexosaminidase (NAG) activity.

Oláh AV, Price RG, Csáthy L, Országh E, Oláh E, Varga J.

Clin Chem Lab Med. 2004 Mar;42(3):305-6.

PMID:
15080564
13.

Urinary homogentisic acid in alkaptonuric and healthy children.

Oláh AV, Llyés I, Szoke A, Csízy I, Tóth J, Varga J.

Clin Chem Lab Med. 2003 Mar;41(3):356-9.

PMID:
12705346
14.

Urinary N-acetyl-beta-D-glucosaminidase in epileptic children treated with antiepileptic drugs.

Csáthy L, Oláh AV, Clemens B, György I, Varga J.

Arch Dis Child. 2000 Nov;83(5):420-2.

15.

[Age-dependent urinary N-acetyl-beta-D-glucosaminidase activity in healthy children].

Csáthy L, Oláh AV, Pócsi I, Varga J, Balla G, Price RG.

Orv Hetil. 1994 Jun 12;135(24):1301-3. Hungarian.

PMID:
8015825
Items per page

Supplemental Content

Write to the Help Desk